In contrast, Kushner’s emphasis on the key role of the Tourette Syndrome Association and the rich legacy of Arthur and Elaine Shapiro is appropriate and timely. Arthur was a unique figure in American psychiatry—equally passionate about Tourette’s and the mysteries of placebo response. He is still revered by his colleagues as the first dean of modern Tourette syndrome researchers. Indeed, having been diagnosed by Arthur is generally regarded as a badge of distinction, if not honor, by the older generation of Tourette’s patients. Similarly, the impact of the Tourette Syndrome Association, Bill and Eleanor Pearl, and their daughter-in-law, Sue Levi-Pearl, is difficult to overstate. The Tourette Syndrome Association, with its enlightened determination to empower families and do the best by the Tourette patient, continues to be a model of what an advocacy organization can be. Further, its early emphasis on research and its role in convening international symposia in 1982, 1992, and again in 1999 have done much to advance our understanding of this disorder. Personally, it was in the heady atmosphere of the First International Symposium that my commitment took root. An idealizing mentor and a series of small start-up grants from the Tourette Syndrome Association nurtured this interest. Subsequently, a growing circle of articulate and challenging patients has sustained my commitment.